Literature DB >> 16821796

Line-walking method for predicting the inhibition of P450 drug metabolism.

Matthew G Hudelson1, Jeffrey P Jones.   

Abstract

A new method, called line-walking recursive partitioning (LWRP), for partitioning diverse structures on the basis of chemical properties that uses only nine descriptors of the shape, polarizability, and charge of the molecule is described. We use a training set of over 600 compounds and a validation set of 100 compounds for the cytochrome P450 enzymes 2C9, 2D6, and 3A4. The LWRP algorithm itself incorporates elements from support vector machines (SVMs) and recursive partitioning, while circumventing the need for the linear or quadratic programming methods required in SVMs. We compare LWRP with a many-descriptor SVM model, using the same dataset as that described in the literature.(1) The line-walking method, using nine descriptors, predicted the validation set with about 84-90% accuracy, a success rate comparable to that of the SVM method. Furthermore, line-walking was able to find errors in the assignment of inhibitor values within the validation set for the 2C9 inhibitors. When these errors are corrected, the model predicts with an even higher level of accuracy. Although this method has been applied to P450 enzymes, it should be of general use in partitioning molecules on the basis of function.

Mesh:

Substances:

Year:  2006        PMID: 16821796      PMCID: PMC2871544          DOI: 10.1021/jm0601553

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  23 in total

1.  QSAR model for drug human oral bioavailability.

Authors:  F Yoshida; J G Topliss
Journal:  J Med Chem       Date:  2000-06-29       Impact factor: 7.446

2.  Computational models for cytochrome P450: a predictive electronic model for aromatic oxidation and hydrogen atom abstraction.

Authors:  Jeffrey P Jones; Michael Mysinger; Kenneth Ray Korzekwa
Journal:  Drug Metab Dispos       Date:  2002-01       Impact factor: 3.922

Review 3.  Atypical kinetic profiles in drug metabolism reactions.

Authors:  J Matthew Hutzler; Timothy S Tracy
Journal:  Drug Metab Dispos       Date:  2002-04       Impact factor: 3.922

4.  Use of robust classification techniques for the prediction of human cytochrome P450 2D6 inhibition.

Authors:  Roberta G Susnow; Steven L Dixon
Journal:  J Chem Inf Comput Sci       Date:  2003 Jul-Aug

Review 5.  Effects of the antifungal agents on oxidative drug metabolism: clinical relevance.

Authors:  K Venkatakrishnan; L L von Moltke; D J Greenblatt
Journal:  Clin Pharmacokinet       Date:  2000-02       Impact factor: 6.447

Review 6.  Effect of genetic polymorphisms in cytochrome p450 (CYP) 2C9 and CYP2C8 on the pharmacokinetics of oral antidiabetic drugs: clinical relevance.

Authors:  Julia Kirchheiner; Ivar Roots; Mark Goldammer; Bernd Rosenkranz; Jürgen Brockmöller
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

Review 7.  Pharmacophore and three-dimensional quantitative structure activity relationship methods for modeling cytochrome p450 active sites.

Authors:  S Ekins; M J de Groot; J P Jones
Journal:  Drug Metab Dispos       Date:  2001-07       Impact factor: 3.922

8.  A refined 3-dimensional QSAR of cytochrome P450 2C9: computational predictions of drug interactions.

Authors:  S Rao; R Aoyama; M Schrag; W F Trager; A Rettie; J P Jones
Journal:  J Med Chem       Date:  2000-07-27       Impact factor: 7.446

9.  Apparent mechanism-based inhibition of human CYP3A in-vitro by lopinavir.

Authors:  James L Weemhoff; Lisa L von Moltke; Clemens Richert; Leah M Hesse; Jerold S Harmatz; David J Greenblatt
Journal:  J Pharm Pharmacol       Date:  2003-03       Impact factor: 3.765

10.  Generation and validation of rapid computational filters for cyp2d6 and cyp3a4.

Authors:  Sean Ekins; Jennifer Berbaum; Richard K Harrison
Journal:  Drug Metab Dispos       Date:  2003-09       Impact factor: 3.922

View more
  3 in total

1.  The effects of nitrogen-heme-iron coordination on substrate affinities for cytochrome P450 2E1.

Authors:  Jeffrey P Jones; Carolyn A Joswig-Jones; Michelle Hebner; Yuzhuo Chu; Dennis R Koop
Journal:  Chem Biol Interact       Date:  2011-05-10       Impact factor: 5.192

2.  Cytochrome P450 2C9 type II binding studies on quinoline-4-carboxamide analogues.

Authors:  Chi-Chi Peng; Jonathan L Cape; Tom Rushmore; Gregory J Crouch; Jeffrey P Jones
Journal:  J Med Chem       Date:  2008-12-25       Impact factor: 7.446

Review 3.  Considerations and recent advances in QSAR models for cytochrome P450-mediated drug metabolism prediction.

Authors:  Haiyan Li; Jin Sun; Xiaowen Fan; Xiaofan Sui; Lan Zhang; Yongjun Wang; Zhonggui He
Journal:  J Comput Aided Mol Des       Date:  2008-06-24       Impact factor: 3.686

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.